Biogen Spain S.L.
Guido Decap Carrasco. VP & Managing Director
Address: Paseo de la Castellana, 41 - 2º.
City: 28046 Madrid
Province: Madrid
Phone: 34 91 310 7110
Fax: 34 91 310 71 11
Mission and Objectives
VISION: With passion, purpose and partnerships, we transform scientific discoveries into advances in human healthcare.
MISSION: We create new standards of care in neurology, oncology and immunology through our pioneering research, our global development, manufacturing and commercial capabilities.
CORE VALUES: Courageous Innovation. Quality, Integrity, Honesty. Team as a Source of Strength. Commitment to Those We Serve Growth, Transformation and Renewal. Consistent with our core values, we as individuals and as a corporation are dedicated to creative and constructive growth, transformation and renewal as a source of inspiration and vitality. Stating your corporate principles is one thing; At Biogen Idec, we live these principles every day. They are the soul of the company.
Products/Services, Areas of interest for future collaborations/Alliances
With our stated mission to create new standards of care for unmet medical needs, Biogen Idec is focused on five therapeutic areas: Neurology, Immunology, Oncology, Cardiopulmonary and Hemophilia. These are areas in which we have both proven expertise and products in our pipeline that we believe can lead to first-in-class or best-in-class molecules. Within each area, we have selected targets based on both biology and the pathophysiology of disease.
TYSABRI® (natalizumab) is a treatment approved for relapsing forms of MS in the United States and relapsing-remitting MS in the European Union.
AVONEX® (Interferon beta-1a) has the most treatment experience for relapsing forms of MS worldwide, with more than 135,000 patients on therapy. It is used worldwide as a treatment for relapsing forms of MS to slow the progression of disability and reduce relapses.
At Biogen Idec, we believe strongly in the value of successful partnerships, and we do everything we can to make them work. If your company is in the later stages of development, Biogen Idec can provide a wealth of resources to help successfully commercialize your product.
Our approach to partnerships is driven by two core principles that promote success: respect and flexibility.
We are interested in partnerships in our core therapeutic areas, which include neurology, oncology and immunology. In addition, we welcome products in acute care, including cardiovascular, hemophilia, infectious disease, and other products used in a hospital environment. We also have active programs in hemophilia research and development. In fact, we are open to partnerships in additional therapeutic areas that lend themselves to a specialty biopharma business model.

Biogen Spain S.L.
Developed by Web4Bio